Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Medikine, Inc. logo — Engineering cytokine mimetics to change the course of seriou...

Medikine, Inc.

Engineering cytokine mimetics to change the course of serious diseases

Founded 2008 United States Menlo Park, United States 6 employees Biotechnology, Health Care

General Information

Company Name Medikine, Inc.
Founded Year 2008
Location United States Menlo Park, United States +1
Founders / Decision Makers
Team member Team member Team member
Employees 6
Industries Biotechnology, Health Care
Social

Get notified when Medikine, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Medikine, Inc.

Medikine, Inc. is a biopharmaceutical company focused on revolutionizing the discovery of oncology, autoimmune disorder, and infectious disease therapeutics through its innovative drug discovery platform. The company's lead product candidate MDK-703, set to commence clinical trials in 2022, is an Fc-fusion protein containing an IL-7 PEPTIKINE, designed to emulate the beneficial properties of IL-7 without the generation of neutralizing antibodies. Additionally, Medikine has identified novel PEPTIKINES that activate the IL-2/15βγc receptor, offering potential for bispecifics with differentiated profiles. The company, founded in 2008, is spearheaded by a team of industry veterans with extensive experience in pioneering drug discovery technology and developing immuno-oncology therapeutics. Medikine aims to advance its pipeline assets through clinical development while seeking partnerships to expand into clinical-stage opportunities. For more details, visit www.medikine.com. Medikine's disruptive drug discovery platform and the potential of its lead product candidate make it an intriguing company for venture capital investment, especially considering its focus on therapeutics for serious diseases. As a prospective investor, it would be valuable to monitor the progress of MDK-703's clinical trials in 2022 and the company's efforts to seek partnerships for further expansion.

Taxonomy: Biopharmaceuticals, Drug discovery, Oncology therapeutics, Autoimmune disorders, Infectious disease therapeutics, PEPTIKINES, Fc-fusion proteins, IL-7 antagonist, IL-2/15βγc receptor agonists, Bispecific therapeutics, Immuno-oncology, Clinical trials, Partnership opportunities, Cytokine and growth factor receptor agonists, Drug development technology

No funding data available for Medikine, Inc. yet.

Get notified when Medikine, Inc. raises funding

Medikine, Inc. Alternatives & Competitors

Medikine, Inc. vs
RAPT Therapeutics
RAPT Therapeutics United States

The Science to Overcome Inflammation and Cancer

Series Unknown
149 employees
Advertising, Enterprise Software
Medikine, Inc. vs
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. United States

Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiat...

Post Ipo Equity
77 employees
Biotechnology, Health Care
Medikine, Inc. vs
Apros Therapeutics, Inc.
Apros Therapeutics, Inc. United States

Apros Tx is a drug discovery and development company focused on immunotherapeutics for cancer and in...

2 employees
Biotechnology, Life Sciences

FAQ About Medikine, Inc.

Engineering cytokine mimetics to change the course of serious diseases
Medikine, Inc. was founded in 2008.
Medikine, Inc. is headquartered in Menlo Park, United States.
Medikine, Inc. operates in the following industries: Biotechnology, Health Care.
Medikine, Inc. has approximately 6 employees.
Top alternatives and competitors to Medikine, Inc. include RAPT Therapeutics, Acrivon Therapeutics, Inc., Apros Therapeutics, Inc., BioNTech SE, Oxford BioTherapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Medikine, Inc. and RAPT Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Medikine, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy